181 results
8-K
EX-1.1
TPST
Tempest Therapeutics Inc
20 Jun 24
Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm
8:13am
principles as applied in the United States and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management’s … and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation
8-K
EX-10.1
jck5afg89agjr8
21 Jun 22
Departure of Directors or Certain Officers
7:31am
424B3
ndb4c2b8omgsv np8rq
27 May 22
Prospectus supplement
9:01am
8-K
EX-99.1
9i0 cvtwiwx8l
26 May 22
Tempest Reports Positive TPST-1120 Clinical Data from Phase 1 Trial in Patients with Advanced Solid Tumors at 2022 ASCO Annual Meeting
5:06pm
DEFA14A
mau0z0gm7t9ag
9 May 22
Additional proxy soliciting materials
8:01am